Generate Biomedicines's logo

Generate Biomedicines Stock and Valuation

Pharmaceuticals and Biotechnology
Year Founded
2018
Headquarters
Cambridge, MA
Employees
264

Generate Biomedicines Valuation Estimate

Based on UpMarket valuation model
$1.64 billion

Generate Biomedicines Valuation as of Last Funding Round

As of 09/06/23, according to PitchBook Data, Inc.
$2.00 billion

Want to buy Generate Biomedicines stock?

I am an accredited investor and understand that UpMarket has a minimum investment of $50,000.
People like you have invested
over $150 million with UpMarket

Generate Biomedicines Company Overview

Generate Biomedicines is a pioneering therapeutics company at the forefront of generative biology, machine learning, and biological engineering. Using their innovative Generate Platform, they have revolutionized the way medicines are created by expanding the breadth of technical possibilities. This breakthrough in generative biology represents a fundamental shift in drug discovery, allowing Generate Biomedicines to generate medicines on demand across multiple therapeutic modalities with unprecedented speed and success rates. With a dedicated team and state-of-the-art facilities, they are building the future of medicine.

Generate Biomedicines Valuation History

Generate Biomedicines Stock Price

The stock price of Generate Biomedicines can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.

For illustrative purposes, however, assuming Generate Biomedicines has issued 250 million shares, at the estimated UpMarket valuation of $1.64 billion, each share of Generate Biomedicines stock would be worth $6.57.

Buy Generate Biomedicines Stock

If you would like to buy shares in Generate Biomedicines, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”

One of our investor relations team members will contact you to discuss Generate Biomedicines stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.

UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Generate Biomedicines as well.

Generate Biomedicines Management

Name Position
Michael Nally CEO
Jason Silvers CFO
Gevorg Grigoryan Ph.D CTO

Generate Biomedicines Investors

T. Rowe Price

Fidelity Management & Research

Morningside Group

March Capital

ARCH Venture Partners

Alaska Permanent Fund

Partners Investment

Abu Dhabi Investment Authority

Generate Biomedicines Related Companies

About UpMarket

UpMarket's mission is to unlock the private markets for individual investors.

We provide access to a range of asset classes and investment strategies that span private equity, hedge funds, crypto, real estate, and other alternative assets.

The problem

Historically, accessing private market investments had these challenges:
  • A large barrier to entry due to high investment minimums
  • Time-intensive because sourcing deals is a lot of work even if you’ve got a great network, and
  • Costly because of investment-related diligence costs, paperwork, and legal fees

The solution

UpMarket works to address these barriers for individual investors by:
  • Offering lower investment minimums
  • Sourcing and conducting diligence on opportunities for investors, empowering them to pick and choose from pre-screened opportunities
  • Making the investment process entirely digital, straightforward, and easy to manage from a single portal
Individuals like you have invested over $150 Million with UpMarket.

UpMarket Investment Curation Process

Upmarket curates and conducts diligence on every investment opportunity we offer.

We review every offering’s strategy, risk management, liquidity management, fees and expenses, valuation methodology, tax matters, as well as the fund’s third-party providers including legal counsel, auditor, administrator, and custodian.

We aim to offer our clients investments from disciplined managers that pursue unique strategies across an array of asset classes.

Our goal is to empower you to build a portfolio that best meets your individual Investment objectives.

Unlock the private markets today, with UpMarket.